Gangrene as an initial manifestation of a catastrophic antiphospholipid syndrome;Gangrena como manifestación inicial de un síndrome antifosfolipídico catastrófico

Reumatologia Clinica

Volumn 4, Issue 3, 2008, Pages 119-122

  Vázquez Fuentes, Noelia ^a   García, Sergio Tejero ^a   González, Fernando Carnicero ^a   Bagur, Irene Martínez ^a   De Torres, Rafael Merino ^a   Gutiérrez, José Javier Querol ^a   Laza, Enrique Manuel Laza ^a   Gutiérrez, Juan Carlos Querol ^a  

^a Hospital Ingesa   (Spain)

Author keywords

Catastrophic antiphospholipid syndrome; Early diagnosis and treatment; Gangrene

Indexed keywords

CEFTRIAXONE; CLINDAMYCIN; CYCLOPHOSPHAMIDE; HEPARIN; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISONE;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; CITROBACTER FREUNDII; DRUG PULSE THERAPY; EARLY DIAGNOSIS; FEMALE; GANGRENE; HUMAN; LIMB ISCHEMIA; LIVEDO RETICULARIS; PROGNOSIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 45849083492     PISSN: 1699258X     EISSN: 18851398     Source Type: Journal    
DOI: 10.1016/S1699-258X(08)71816-3     Document Type: Article

References (11)

1. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement of an update of the classification criteria for definite antiphospholipid syndrome. J Thromb Haemost. 2006;4:295-306.
2. Khamashta M, Font J. Síndrome antifosfolípido. En: Font J, Khamashta M, Vilardell M, editores. Lupus eritematoso sistémico. Barcelona: mra; 2001. p. 452-3.
3. Losckshin MD. Síndrome de anticuerpos antifosfolipídicos. En: Ruddy S, Harris ED, Sledge CB, Budd RC, Sergent JS, editores. Reumatología. Madrid: Marbán; 2003. p. 1146-7.
4. Bayraktar UD, Erkan D, Bucciarelli S, Espinosa G, Asherson RA. The clinical spectrum of catastrophic antiphospholipid syndrome in the absence and presence of lupus. J Rheumatol. 2007;34:346-52.
5. Espinosa G, Cervera R, Asherson RA. Catastrophic antiphospholipid syndrome and sepsis. A common link? J Rheumatol. 2007;34:923-6.
6. Asherson RA. Multiorgan failure and antiphospholipid antibodies: the catastrophic antiphospholipid (Asherson's) syndrome. Inmunobiology. 2005;210:727-33.
7. Asherson RA, Cervera R, De Groot PG, Erkan D, Boffa MC, Piette JC. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus. 2003;12:530-4.
8. Asherson RA, Frances C, Iaccarino L, Khamashta MA, Malacarne F, Piette JC, et al. The antiphospholipid antibody syndrome: diagnosis, skin manifestations and current therapy. Clin Exp Rheumatol. 2006;24:46-51.
9. Amital H, Levy Y, Davidson C, Lundberg I, Harju A, Kosach Y, et al. Catastrophic antiphospholipid syndrome: remission following leg amputation in two cases. Semin Arthritis Rheum. 2001;31:127-32.
10. Erkan D, Asherson RA, Espinosa G, Cervera R, Font J, Piette JC, et al. Long term outcome of catastrophic antiphospholipid síndrome survivors. Ann Rheum Dis. 2003;62:530-3.
11. Bucciarelli S, Espinosa G, Cervera R, Erkan D, Gómez-Puerta JA, Ramos-Casals M, et al. Mortality in the catastrophic antiphospholipid syndrome. Arthritis Rheum. 2006;54:2568-76.